CompletedPhase 2NCT00003667
Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
Studying Extraskeletal Ewing sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Paul A. Meyers, MDMemorial Sloan Kettering Cancer Center
- Intervention
- cyclophosphamide(drug)
- Eligibility
- 3-60 years · All sexes
- Timeline
- 1998 – 2000
Study locations (2)
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003667 on ClinicalTrials.gov